A detailed history of Penserra Capital Management LLC transactions in Organon & Co. stock. As of the latest transaction made, Penserra Capital Management LLC holds 15,563 shares of OGN stock, worth $249,008. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,563
Holding current value
$249,008
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $290,249 - $358,415
15,563 New
15,563 $297,000
Q3 2023

Nov 15, 2023

BUY
$16.59 - $23.77 $35,701 - $51,153
2,152 Added 131.06%
3,794 $65,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $31,641 - $40,442
1,642 New
1,642 $34,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.07B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.